Post

Prospect for Stent Market in India are Upbeat

Prospect for Stent Market in India are Upbeat

While Johnson & Johnson’s Cordis withdrew from India, companies such as Abbott Laboratories – Vascular, Boston Scientific Corporation, Medtronic Inc. and other players like Biotronik, Sahajanand Medical Technologies, Meril Life Sciences and Translumina Therapeutics are  vying to expand their presence in India through investments in the coronary stent market, according to a research report. Stent sales in India approach half a billion dollars annually according to this report, a number that seems high to the The India Expert. However we do expect double digit growth in India for the next decade.

Boston Scientific Corporation is strengthening its presence in the emerging nations with Brazil, Russia, India and China (BRIC) and recorded 22% growth rate in these countries in the last quarter. Medtronic management is targeting 20% of its revenues from the emerging market eyeing incremental revenues of $2.5 billion over the next 5 years (and this was before the proposed merger with Covidien).

Share

About Amritt

Who We Are

Small or big, your business will love our financial help and business consultations! We are happy when our clients are too… Actually, this is quite simple to achieve – because each time we help them in sorting out different accounting intricacies or save the day before filing the taxes, they are happy indeed! And so are we.   

We have over Twenty years of experience helping our clients succeed in India

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Blog
Page
Dictionary
Comparisons
Capabilities
India Business Guide
Services
Private
Speaking
Insights
White Papers
News
Newsletters
Clients
Case Studies
Companies In India
Webinars
Presentations
Industries